🔬🧬 Oncology Updates: New Brain Cancer Therapy, HER2 NSCLC Breakthrough, Global Liver Cancer Trial and More
From cutting-edge glioblastoma combinations to the first PROTAC breast cancer therapy and high-impact colorectal cancer trials—this week’s oncology roundup showcases breakthroughs reshaping cancer treatment and precision medicine.
💡 Key Highlights This Week:
✅ FDA clears Starlight’s STAR-001 + spironolactone trial in recurrent glioblastoma; market potential estimated at $3–5B
✅ Boehringer’s HERNEXEOS earns accelerated FDA approval for HER2-mutant NSCLC with 75% response rate in Phase Ib
🧬 NCCN updates small cell lung cancer guidelines to include LEMS testing and amifampridine; up to 90% of cases undiagnosed
🧪 Arvinas’ vepdegestrant becomes first PROTAC breast cancer therapy to reach NDA stage; FDA decision expected June 5, 2026
🚀 ProteinQure secures FDA & Health Canada clearance for AI-designed PQ203 in triple-negative breast cancer with Fast Track status
🌏 Akeso to launch global trial of cadonilimab + lenvatinib in PD-1–resistant liver cancer; compares combo vs lenvatinib alone
🧩 FDA clears Anbogen’s triplet therapy for colorectal cancer targeting pMMR/non-MSI-H cases—representing greater than 95 percent of patients resistant to immunotherapy
📡 Lantheus NDA accepted for high-output PSMA PET agent, boosting batch capacity by ~50%; decision due March 6, 2026
🇨🇦 Imfinzi approved in Canada as first perioperative immunotherapy for muscle-invasive bladder cancer; NIAGARA trial showed 32% reduced recurrence or death risk
🇨🇳 Junshi’s toripalimab + disitamab vedotin sNDA accepted in HER2-positive urothelial cancer; met PFS and OS endpoints over chemotherapy
🎯 Whether you’re following targeted therapies, AI-driven drug design, or global oncology trial launches—this episode delivers the must-know updates driving innovation across cancer care.
📢 Stay Ahead in Oncology Research!
✅ Like, share, and subscribe for weekly updates on oncology breakthroughs and cancer immunotherapy
#Oncology #CancerResearch #FDAApproval #ClinicalTrials #BreastCancer #LungCancer #LiverCancer #ColorectalCancer #ProstateCancer #BladderCancer #Glioblastoma #NSCLC #Immunotherapy #PROTAC #AIinHealthcare #MedicalInnovation #LucidQuest #BiotechNews #PharmaInnovation #SolidTumors #HealthcareUpdates